Global Breast Cancer Liquid Biopsy Market to Reach $963.2 Million by 2030
The global market for Breast Cancer Liquid Biopsy estimated at US$106.7 Million in the year 2022, is projected to reach a revised size of US$963.2 Million by 2030, growing at a CAGR of 31.7% over the analysis period 2022-2030. Reagent Kits, one of the segments analyzed in the report, is projected to record 32.4% CAGR and reach US$730.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 31% CAGR for the next 8-year period.The U.S. Market is Estimated at $31.2 Million, While China is Forecast to Grow at 30.4% CAGR
The Breast Cancer Liquid Biopsy market in the U.S. is estimated at US$31.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$161.4 Million by the year 2030 trailing a CAGR of 30.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 28.6% and 27.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 23.6% CAGR.Select Competitors (Total 34 Featured) -
- Biodesix, Inc.
- Bio-Rad Laboratories
- Cynvenio Biosystems, Inc.
- Fluxion Biosciences, Inc.
- Genomic Health, Inc.
- Guardant Health, Inc.
- Illumina
- Isogen Life Science B.V.
- Menarini Silicon Biosystems
- Myriad Genetics
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biodesix, Inc.
- Bio-Rad Laboratories
- Cynvenio Biosystems, Inc.
- Fluxion Biosciences, Inc.
- Genomic Health, Inc.
- Guardant Health, Inc.
- Illumina
- Isogen Life Science B.V.
- Menarini Silicon Biosystems
- Myriad Genetics
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 106.7 Million |
Forecasted Market Value ( USD | $ 963.2 Million |
Compound Annual Growth Rate | 31.7% |
Regions Covered | Global |